Related Experiment Video
Updated: Jul 5, 2026
11:20
Osmotic Avoidance in Caenorhabditis elegans: Synaptic Function of Two Genes, Orthologues of Human NRXN1 and NLGN1, as Candidates for Autism
Published on: December 11, 2009
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
1Program of Developmental Neurobiology, Institute of Molecular Medicine and Genetics, Department of Neurology, Medical College of Georgia, Augusta, Georgia 30912, USA. lmei@mcg.edu
Nature Reviews. Neuroscience
|May 15, 2008
Summary
Genetic variations in neuregulin 1 (NRG1) and ErbB4 are linked to schizophrenia risk. Understanding these genes
Area of Science:
- Neuroscience and Genetics
- Psychiatric Disorders Research
Background:
- Schizophrenia affects 1% of the population and remains poorly understood.
- Genetic factors, including variations in neuregulin 1 (NRG1) and its receptor ErbB4, are implicated in schizophrenia risk.
Purpose of the Study:
- To explore the role of NRG1 and ErbB4 gene variations in schizophrenia.
- To advance the understanding of the biological mechanisms underlying schizophrenia.
- To identify potential therapeutic targets for schizophrenia treatment.
Main Methods:
- Review of recent genetic studies on schizophrenia.
- Analysis of gene polymorphisms in NRG1 and ErbB4.
- Investigation of NRG1 and ErbB4 functions in biological pathways.
Main Results:
- Identified specific gene variations in NRG1 and ErbB4 associated with schizophrenia across diverse populations.
- Elucidated the functional impact of these genetic variations on neural pathways.
- Established a clearer link between NRG1/ErbB4 dysregulation and schizophrenia pathogenesis.
Conclusions:
- Altered function of NRG1 and ErbB4 pathways is a significant contributor to schizophrenia.
- Genetic variations in NRG1 and ErbB4 provide insights into schizophrenia's biological basis.
- Targeting NRG1 and ErbB4 pathways may offer novel therapeutic strategies for schizophrenia.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:30Neurulation
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...